No Detail Found!

Differential Expression of Placental Growth Factor, Transforming Growth Factor-b and Soluble Endoglin in Peripheral Mononuclear Cells in Preeclampsia.

Author(s)
Zaima Ali Department of Physiology, Lahore Medical and Dental College, Lahore, Pakistan
Saba Khaliq Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan
Saima Zaki Department of Obstetrics and Gynecology, Jinnah Hospital, Lahore, Pakistan
Hafiz Usman Ahmad Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan
Khalid Pervaiz Lone Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan
Abstract
Objective: To measure the peripheral blood mononuclear cells (PBMCs) mRNA expression of placental growth factor (PlGF), Transforming growth factor beta (TGF-b), and soluble Endoglin (sEng) in the blood of preeclamptic and normotensive pregnant women. Study Design: Cross-sectional analytical study. Place and Duration of Study: Department of Physiology and Cell Biology, University of Health Sciences, Lahore, from November 2016 to April 2018. Methodology: The study included 50 normotensive and 57 preeclamptic patients (18-40 years of age), all in the third trimester of pregnancy. The preeclamptic group was further divided into early-onset preeclampsia (EOP) and late-onset preeclampsia (LOP). Blood samples from patients and healthy controls were collected and mRNA expression was measured (18 patients and 18 controls) by real time PCR. Statistical analyses were done using SPSS (version 22). The values were considered significant at 0.05 level of significance. Results: The PBMCs mRNA expression of PlGF, TGF-b and sEng were significantly different between the preeclampsia and control group (p<0.001). A significant decrease in expression of TGF-b was observed in LOP group compared to controls (p<0.001); whereas, the difference in the expression of EOP compared to controls was not significant (p=0.12). Similar to TGF-b, the expression of PlGF was significantly decreased among EOP and LOP compared to controls. Detailed analysis of sEng showed significantly increased expression in both EOP and LOP as compared to healthy group (p<0.001). Conclusion: There is a significant difference in extra-placental expression of PlGF, and sEng in preeclampsia.
Publication Details
Page(s) 235-239
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 3, Year: 2019

Request the full text from PASTIC

References
UzanJ,CarbonnelM,PiconneO,AsmarR,AyoubiJM, 2011.Preeclampsia: pathophysiology, diagnosis, and management,Vasc Health Risk Manag 7 467 -74
OsungbadeKO,IgeOK, 2011.Public health perspectives of preeclampsia in developing countries: implication for health system strengthening,J Pregnancy 481095 -
CanM,SancarE,HarmaM,GuvenB,MunganG,AcikgozS., 2011.Inflammatory markers in preeclamptic patients,Clin Chem Lab Med 49 1469 -72
ParkJE,ChenHH,WinerJ,HouckKA,FerraraN., 1994.Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR,J Biol Chem 269 25646 -54
GilleH,KowalskiJ,LiB,Le CouterJ,MoffatB,ZioncheckTF, 2001.Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants,J Biol Chem 276 3222 -30
TakahashiH,ShibuyaM., 2005.The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions,Clin Sci (Lond 109 227 -41
LebrinF,GoumansMJ,JonkerL,CarvalhoRL,ValdimarsdottirG,ThorikayM, 2004.Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction,EMBO J 23 4018 -28
AggarwalPK,ChandelN,JainV,JhaV., 2012.The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia,J Hum Hypertens 26 236 -41
LevineRJ,LamC,QianC,YuKF,MaynardSE,SachsBP, 2006.Soluble endoglin and other circulating antiangiogenic factors in preeclampsia,N Engl J Med 355 992 -1005
PerucciLO,GomesKB,FreitasLG,GodoiLC,AlpoimPN,PinheiroMB, 2014.Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia,PloS One 9 e97632 -
ToporsianM,GrosR,KabirMG,VeraS,GovindarajuK,EidelmanDH, 2005.A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia,Circ Res 96 684 -92
RabajdovaM,DudicR,UrbanP,DudicovaV,UrdzikP,MarekovaM., 2017.Analysis of transcriptional activities of angiogenic biomarkers during intrauterine complications leading to preterm birth,Eur Rev Med Pharmacol Sci 21 1433 -42
AndraweeraPH,DekkerGA,LaurenceJA,RobertsCT, 2012.Placental expression of VEGF family mRNA in adverse pregnancy outcomes,Placenta 33 467 -72
KimSC,ParkMJ,JooBS,JooJK,SuhDS,LeeKS, 2012.Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia,J Obstet Gynaecol Res 38 665 -73
FarinaA,ZucchiniC,SekizawaA,PurwosunuY,de SanctisP,SantarsieroG, 2010.Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks,Am J Obstet Gynecol 203 575 -7
OkazakiS,SekizawaA,PurwosunuY,FarinaA,WibowoN,OkaiT, 2007.Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women,Obstet Gynecol 110 1130 -6
PaivaP,WhiteheadC,SaglamB,PalmerK,Tong S, 2011.Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia,J Clin Endocrinol Metab 96 E1807 -15
RenY,WangH,QinH,YangJ,WangY,JiangS, 2014.Vascular endothelial growth factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance,Pak J Med Sci 30 634 -7
SekizawaA,PurwosunuY,FarinaA,ShimizuH,NakamuraM,WibowoN, 2010.Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation,BJOG 117 557 -64
ToftJH,LianIA,TarcaAL,ErezO,EspinozaJ,EideIP, 2008.Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies,J Matern Fetal Neonatal Med 21 267 -73
SinghM,OrazulikeNC,AshmoreJ,KonjeJC, 2013.Changes in maternal serum transforming growth factor beta-1 during pregnancy: a cross-sectional study,Biomed Res Int 318464 -
Martinez-FierroML,Garza-VelozI,Carrillo-SanchezK,Martinez-GaytanV,Cortes-FloresR,Ochoa-TorresMA, 2014.Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia,Hypertens Pregnancy 33 191 -203
WangY,ChenQ,ZhaoM,WaltonK,HarrisonC, 2017.Multiple soluble TGF-beta receptors in addition to soluble endoglin are elevated in preeclamptic serum and they synergistically inhibit TGF-beta signaling,J Clin Endocrinol Metab 102 3065 -74
RomeroR,NienJK,EspinozaJ,TodemD,FuW,ChungH, 2008.A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate,J Matern Fetal Neonatal Med 21 9 -23
NishizawaH,OtaS,SuzukiM,KatoT,SekiyaT,KurahashiH, 2011.Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction,Reprod Biol Endocrinol 9 107 -
0

Citations

0

Downloads

60

Views